- Issuer ticker
-
BIIB
- Reported as of
-
26 Jun 2023
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
28 Jun 2023, 19:06:11 UTC
Filing notes and source
Key filing fact
Eric K. Rowinsky filed Form 4 for BIOGEN INC. (BIIB) on 28 Jun 2023.
Key facts
- This page summarizes Eric K. Rowinsky's Form 4 filing for BIOGEN INC. (BIIB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Jun 2023, 19:06.
Change
- Previous filing in this sequence was filed on 16 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIIB
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +960
- Change %
- +5%
- Price
-
$0.000000
- Shares after
- 20,174
- Date
- 26 Jun 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.